The control of multiresistant organisms (MROs) is made difficult by a large reservoir of unrecognised, asymptomatic colonised patients. Hence, active screening is generally used as part of a multifaceted infection control intervention. For MRGNB the ratio of colonised to infected patients has been estimated at~8:1 for extended spectrum beta-lactamases 2 and 9:1 for carbapenem-resistant Enterobacteriaceae (CRE) 3 . In addition to this, the very mechanism by which antibiotic resistance is transferred between common species like Escherichia coli and Klebsiella pneumoniae is such that resistance acquisition can be highly , although the latter is more practical. Using more than one screening specimen or specimen type may increase sensitivity 6 , but again for practical purposes one specimen is usual. Concurrent antibiotic use has a variable impact on MRO faecal density 10 but logic dictates that detection of a reservoir of resistance is more likely in the presence of relevant selection pressure.
The control of multiresistant organisms (MROs) is made difficult by a large reservoir of unrecognised, asymptomatic colonised patients. Hence, active screening is generally used as part of a multifaceted infection control intervention. For MRGNB the ratio of colonised to infected patients has been estimated at~8:1 for extended spectrum beta-lactamases 2 and 9:1 for carbapenem-resistant Enterobacteriaceae (CRE) 3 . In addition to this, the very mechanism by which antibiotic resistance is transferred between common species like Escherichia coli and Klebsiella pneumoniae is such that resistance acquisition can be highly Increased specimen volume and a higher MRO faecal density both increase yield of screening 7, 8 . For this reason faecal samples may perform better than rectal swabs 9 , although the latter is more practical. Using more than one screening specimen or specimen type may increase sensitivity 6 , but again for practical purposes one specimen is usual. Concurrent antibiotic use has a variable impact on MRO faecal density 10 but logic dictates that detection of a reservoir of resistance is more likely in the presence of relevant selection pressure.
Active screening specimens may be processed in the laboratory using phenotypic (culture based) or direct genotypic (amplification and detection of bacterial DNA) methods. There is no consensus as to the optimal laboratory processing method but factors that should be considered are local molecular epidemiology (including the likely minimum inhibitory concentration (MIC) of relevant antibiotics against target isolates), availability of expertise and equipment, cost, capacity for integration into laboratory workflow and test performance including sensitivity, specificity, limit of detection and turnaround time. Currently, phenotypic methods are more widely used, although we anticipate that with advances in automation, data
In Focus processing and reductions in cost these will be replaced by genotypic methods in the future. The main advantages of genotypic methods are shorter achievable turnaround times (and potential for point-of-care testing), improved sensitivity and reduced need for human resources. Potential disadvantages of genotypic methods include higher costs, a need for expertise/complex equipment and the lack of an isolate for susceptibility testing or typing if using direct screening without culture.
Regardless of which screening method (phenotypic or genotypic) is used for detecting transmissible antibiotic resistance, one must accept a trade-off between (a) the risk of overlap between the highest naturally occurring MIC of wild-type organisms (that is, those without the targeted resistance) and those with a low MIC in the presence of a relevant mechanism, especially one that is readily transmissible to an organism in which it facilitates high levels of resistance and (b) the failure to identify a new or variant mechanism.
This is illustrated by the overlapping ceftazidime MICs of local E. coli populations with common transmissible ESBL genes ( Figure 1 ).
We will now use the example of CRE to examine the spectrum of Genotypic screens (even direct PCR) can have high predictive value if informed by local epidemiology. The negative predictive value of genetic testing for resistance to aminoglycosides and/or major betalactams can be greater than 99.5% in a country like Australia with relatively low pre-test probability 25 , but the optimal frequency with which this must be surveyed and the applicability of this approach in other countries, including high-prevalence settings, remains to be tested.
In summary, when used alongside other infection control measures, active screening is a useful tool that may assist with limiting the spread of MRGNBs. There is no consensus as to the optimal laboratory processing method, although genotypic methods are likely to become the most frequently used in the future. An understanding of local molecular epidemiology and MICs will assist laboratories in selecting the most appropriate screening assay for their setting. In Focus
